Acquisitions (Tables)

9 Months Ended

Jun. 30, 2018

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the Company’s allocation of the purchase consideration to assets acquired and liabilities assumed at the Ultra Chem Closing Date:



	Purchase Consideration Allocation
Accounts receivable	$	13.7
Inventory	9.1
Other current assets	2.4
Property and equipment	0.5
Customer-related intangible	24.0
Trade name	0.3
Non-compete agreements	3.9
Other non-current assets	2.5
Goodwill	28.0
Total assets acquired	84.4

Short-term borrowings	0.9
Accounts payable	12.1
Other current liabilities	4.1
Deferred tax liability — non-current	8.4
Other non-current liabilities	2.2
Total liabilities assumed	27.7

Net assets acquired	$	56.7

Schedule of Consolidated Pro Forma Financial Information

The unaudited consolidated pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Ultra Chem Acquisition occurred on October 1, 2015.



	Three Months Ended June 30,				Nine Months Ended June 30,
	2018		2017		2018		2017
Sales and operating revenues	$	1,046.4	$	942.7	$	3,017.0	$	2,690.4
Operating income	$	40.1	$	26.1	97.9		38.4
Net income from continuing operations	$	17.5	$	11.7	44.4		3.1
Net income	$	17.5	$	11.7	44.4		3.1
Basic net income per share	$	0.23	$	0.15	0.58		0.04
Diluted net income per share	$	0.23	$	0.15	0.58		0.04

Pro forma weighted average number of common shares outstanding
Basic	76,797,414		76,743,853		76,795,551		76,745,396
Diluted	76,983,350		76,828,868		76,952,758		76,830,296